Therefore, as a continuation of our previous research, in the present investigation, we assess whether another ligand of CXCR2, such as CXCL1, as well as a second receptor of CXCL8, such as CXCR2, might be used as potential biomarkers for CRC. The gene discussed is CXCR2; the disease is colorectal carcinoma.